MMRGlobal Subsidiary Receives Clinical Trials Patent, as University of Texas Southwestern Medical Center & the University of Manchester Validate Patient Engagement in Clinical Trials - Seite 2

According to MMRGlobal CEO Robert H. Lorsch, "The '212 patent is a whole new patent, not a continuation patent. This patent will allow MMR to potentially generate revenue from licensing to organizations that routinely conduct clinical trials for Big Pharma. Because clinical trials are extremely time consuming and expensive, we believe the '212 patent and additional continuation patents coming from this patent will be of significant value to the company and that this value is not reflected in previous valuations of the Company's patents, which have ranged from $600,000,000 to 1.3 billion dollars."

The '212 Patent includes 18 claims directed to methods and systems which provide for self-reporting in clinical trials. Self-reporting may be performed in various ways including receiving data from medical monitoring equipment through various forms of telemedicine services, receiving data created by healthcare providers, the entering of data from the patient including information pertaining to the tracking of taking medications and history of appointments with healthcare professionals, amongst other means. The issued patent also provides for emergency access by family, emergency personnel and physicians to a subset of records contained in a patient account in an emergency.

MyMedicalRecords, Inc. is a practicing entity and a leading provider of secure and easy-to-use Personal Health Records through the MyMedicalRecords PHR, and MMRPro and MMRProPlus document management and imaging systems for healthcare professionals. MMR currently has 13 issued U.S. health IT patents pertaining to Personal Health Records including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; 8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and its newest issued patent, 8,775,212, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. In addition to the U.S., MMR currently has patents issued, pending and/or applied for in 11 other countries or regional authorities including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China, South Korea, Israel and Europe.